BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 10077329)

  • 1. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.
    Jansson A; Goldstein M; Tinner B; Zoli M; Meador-Woodruff JH; Lew JY; Levey AI; Watson S; Agnati LF; Fuxe K
    Neuroscience; 1999 Mar; 89(2):473-89. PubMed ID: 10077329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 and D2 receptor immunoreactivities in the arcuate-median eminence complex and their link to the tubero-infundibular dopamine neurons.
    Romero-Fernandez W; Borroto-Escuela DO; Vargas-Barroso V; Narváez M; Di Palma M; Agnati LF; Larriva Sahd J; Fuxe K
    Eur J Histochem; 2014 Jul; 58(3):2400. PubMed ID: 25308843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.
    Hooks MS; Juncos JL; Justice JB; Meiergerd SM; Povlock SL; Schenk JO; Kalivas PW
    J Neurosci; 1994 Oct; 14(10):6144-52. PubMed ID: 7931568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of dopamine D1 receptor and mu-opioid receptor 1 receptor immunoreactivities in the amygdala and interstitial nucleus of the posterior limb of the anterior commissure: relationships to tyrosine hydroxylase and opioid peptide terminal systems.
    Jacobsen KX; Höistad M; Staines WA; Fuxe K
    Neuroscience; 2006 Sep; 141(4):2007-18. PubMed ID: 16820264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.
    Sesack SR; Aoki C; Pickel VM
    J Neurosci; 1994 Jan; 14(1):88-106. PubMed ID: 7904306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The striatal mosaic in primates: patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum.
    Martin LJ; Hadfield MG; Dellovade TL; Price DL
    Neuroscience; 1991; 43(2-3):397-417. PubMed ID: 1681464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of dopaminergic markers expression in the striatum by neonatal exposure to glutamate during development.
    López-Pérez SJ; Vergara P; Ventura-Valenzuela JP; Ureña-Guerrero ME; Segovia J; Beas-Zárate C
    Int J Dev Neurosci; 2005 Jun; 23(4):335-42. PubMed ID: 15927757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptors in the nucleus accumbens modulate erectile function in a rat model of nonorganic erectile dysfunction.
    Chen G; Yu D; Wu Y; Dong J; Hu L; Feng N
    Andrology; 2022 May; 10(4):808-817. PubMed ID: 35235251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.
    Stanwood GD; McElligot S; Lu L; McGonigle P
    Neurosci Lett; 1997 Feb; 223(1):13-6. PubMed ID: 9058411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors.
    Soderman AR; Unterwald EM
    Brain Res; 2009 Nov; 1296():63-71. PubMed ID: 19699185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
    Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
    Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.
    Wong AC; Shetreat ME; Clarke JO; Rayport S
    Neuroscience; 1999 Mar; 89(1):221-33. PubMed ID: 10051231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens.
    Teicher MH; Andersen SL; Hostetter JC
    Brain Res Dev Brain Res; 1995 Nov; 89(2):167-72. PubMed ID: 8612321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
    Olianas MC; Dedoni S; Boi M; Onali P
    J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.